The endocannabinoid system and psychiatric disorders.

Author(s): Parolaro D, Realini N, Vigano D, Guidali C, Rubino T

DBSF and Neuroscience Center, University of Insubria, Via A. da Giussano 10, 21052 Busto Arsizio (Varese), Italy. [email protected]

Subject: Mood Disorders View the study


The present review summarizes the latest information on the role and the pharmacological modulation of the endocannabinoid system in mood disorders and its potential implication in psychotic disorders such as schizophrenia. Reduced functionality might be considered a predisposing factor for major depression, so boosting endocannabinoid tone might be a useful alternative therapeutic approach for depressive disorders.

Source: Experimental Neurology (Price: $36)
Share Tweet

More medical studies related to Mood Disorders:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

продвижение сайтов в интернете

печать на футболках

seo website